scispace - formally typeset
Open AccessJournal ArticleDOI

Investigation on cell proliferation with a new antibody against thymidine kinase 1.

TLDR
A polyclonal anti‐TK1 antibody against a synthetic peptide from the C‐terminus of human TK1 is developed and demonstrated, demonstrating the exclusive location of TK 1 in the cytoplasm of cells.
Abstract
The cytosolic thymidine kinase 1 (TK1) is one of the enzymes involved in DNA replication. Based on biochemical studies, TK1 is activated at late G1 of cell cycle, and its activity correlates with the cell proliferation. We have developed a polyclonal anti‐TK1 antibody against a synthetic peptide from the C‐terminus of human TK1. Using this antibody, here we demonstrate the exclusive location of TK1 in the cytoplasm of cells. Cell cycle dependent TK1 expression was studied by simultaneous fluorescence staining for TK1 and bromodeoxyuridine, by using elutriated cells, and by quantitation of the amount TK1 in relation to the cellular DNA content. TK1, which was strongly expressed in the cells in S+G2 period, raised at late G1 and decreased during mitosis. The amount of TK1 increased three folds from late G1 to G2. TK1 positive cells were demonstrated in areas of proliferation activity of various normal and malignant tissues. The new anti‐TK1 antibody works in archival specimens and is a specific marker of cell proliferation.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Measuring proliferation in breast cancer: practicalities and applications.

TL;DR: The potential clinical applications of proliferative indices are discussed, including their use as prognostic indicators and predictors of response to systemic therapy.
Journal ArticleDOI

Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1.

TL;DR: Chicken egg yolk immunoglobulins generated to a synthetic 31-amino acid peptide from the C-terminal of human HeLa thymidine kinase 1 (TK1) enzyme are suggested to be potentially useful for serological and immunohistochemical detection of TK1 as an early prognosis and for monitoring patients undergoing treatment.
Journal Article

Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer.

TL;DR: The results indicate that the S-TK1 concentration is higher in patients developing distant and/or loco-regional recurrence 3 months post-surgery.
Journal ArticleDOI

Thymidine kinase and cancer monitoring

TL;DR: The status of TK1 for cancer monitoring and its use as a proliferation marker are summarized and a comprehensive overview about the association of Tk-1 with various entities is given.
Journal ArticleDOI

The role of thymidine kinase in cancer diseases.

TL;DR: Determination of thymidine kinase helps to monitor the follow-up of solid tumours and haematological malignancies as well as indicating the efficacy of adjuvant and palliative chemotherapy.
References
More filters
Journal ArticleDOI

Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis.

TL;DR: It is demonstrated that residues near the carboxyl terminus of TK are essential for the cell cycle phase-specific degradation of the enzyme.
Journal ArticleDOI

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.

TL;DR: It is concluded that s-dTk could be used both as a prognostic marker and to monitor the effect of therapy in NHL patients.
Journal Article

Expression of Cell Cycle-regulated Proteins in Prostate Cancer

TL;DR: The results suggest that immunoreactivity for markers of cellular proliferation may provide useful prognostic information in localized prostate cancer, and they need to be validated in a larger numbers of patients.
Journal ArticleDOI

Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.

TL;DR: Serum TK appears to have some clinical value in such solid tumors as prostate cancer, breast cancer, and small-cell lung cancer, whereas it is not a reliable marker of non-small- cell lung cancer and brain tumors.
Journal ArticleDOI

The Intracellular Localization of Deoxycytidine Kinase

TL;DR: Native dCK is found to be located mainly in the cytoplasm in several cell types, and the enzyme was more concentrated in the perinuclear and cellular membrane area, suggesting the existence of a cy toplasmic retention mechanism that may have an important function in the regulation of the deoxynucleoside salvage pathway.
Related Papers (5)